CLINICAL CORRELATIVE STUDIES OF NEUROBLASTOMA
CLINICAL CORRELATIVE STUDIES OF NEUROBLASTOMA
批准号:
2100738
负责人:
ROBERT Charles SEEGER
金额:
$21.67万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-08-01 至 1998-01-31
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
2000
期刊:
Cancer research
影响因子:
11.2
作者:
[A. Erdreich-Epstein;H. Shimada;S. Groshen;M. Liu;L. Metelitsa;K. Kim;M. Stins;R. Seeger;D. D]
通讯作者:
A. Erdreich-Epstein;H. Shimada;S. Groshen;M. Liu;L. Metelitsa;K. Kim;M. Stins;R. Seeger;D. D
Familial neuroblastoma: report of a kindred with later age at diagnosis.
家族性神经母细胞瘤:诊断时年龄较晚的亲属的报告。
DOI:
10.1097/00043426-199809000-00017
发表时间:
1998
期刊:
Journal of pediatric hematology/oncology
影响因子:
--
作者:
[Lemire,EG, Chodirker,BN, Williams,GJ, Seargeant,LE, Israels,SJ, Phillips,SM, deNanassy,JA, Maris,JM, Yanofsky,RA]
通讯作者:
Yanofsky,RA
Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell lines
绿色荧光蛋白的转导增加了神经母细胞瘤细胞系的氧化应激并增强了对细胞毒性药物的敏感性
DOI:
--
发表时间:
2003
期刊:
影响因子:
--
作者:
[後藤 裕明]
通讯作者:
後藤 裕明
Telomerase expression in primary neuroblastomas.
原发性神经母细胞瘤中端粒酶的表达。
DOI:
10.1016/s0959-8049(97)00287-6
发表时间:
1997
期刊:
European journal of cancer (Oxford, England : 1990)
影响因子:
--
作者:
[Reynolds,CP, Zuo,JJ, Kim,NW, Wang,H, Lukens,JN, Matthay,KK, Seeger,RC]
通讯作者:
Seeger,RC
DOI:
--
发表时间:
2001-08
期刊:
Cancer research
影响因子:
11.2
作者:
[N. Keshelava;J. Zuo;Ping Chen;Sitara N. Waidyaratne;Marian Luna;C. Gomer;T. Triche;C. Reynolds]
通讯作者:
N. Keshelava;J. Zuo;Ping Chen;Sitara N. Waidyaratne;Marian Luna;C. Gomer;T. Triche;C. Reynolds
共 9 条
NATURAL KILLER CELL BASED IMMUNOTHERAPY
-
批准号:7897361
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2010
-
负责人:ROBERT Charles SEEGER
-
依托单位:
Gene Expression of Neuroblastoma and Normal Cells in Bone Marrow Predicts Outcome
-
批准号:8322111
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2010
-
负责人:ROBERT Charles SEEGER
-
依托单位:
RESEARCH SUPPORT SERVICES
-
批准号:7897377
-
项目类别:
-
资助金额:$3.74万
-
财政年份:2010
-
负责人:ROBERT Charles SEEGER
-
依托单位:
Gene Expression of Neuroblastoma and Normal Cells in Bone Marrow Predicts Outcome
-
批准号:8135037
-
项目类别:
-
资助金额:$42.76万
-
财政年份:2010
-
负责人:ROBERT Charles SEEGER
-
依托单位:
Gene Expression of Neuroblastoma and Normal Cells in Bone Marrow Predicts Outcome
-
批准号:7979222
-
项目类别:
-
资助金额:$44.17万
-
财政年份:2010
-
负责人:ROBERT Charles SEEGER
-
依托单位:
Clinical Correlative Studies of Neuroblastoma
-
批准号:7910335
-
项目类别:
-
资助金额:$39.76万
-
财政年份:2009
-
负责人:ROBERT Charles SEEGER
-
依托单位:
RESEARCH SUPPORT SERVICES
-
批准号:6949347
-
项目类别:
-
资助金额:$3.67万
-
财政年份:2005
-
负责人:ROBERT Charles SEEGER
-
依托单位:
IMMUNOTHERAPY
-
批准号:6949340
-
项目类别:
-
资助金额:$19.43万
-
财政年份:2005
-
负责人:ROBERT Charles SEEGER
-
依托单位:
BIOLOGY AND THERAPY OF HIGH-RISK NEUROBLASTOMA
-
批准号:6096781
-
项目类别:
-
资助金额:$180.03万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
BIOLOGY AND THERAPY OF HIGH-RISK NEUROBLASTOMA
-
批准号:6513556
-
项目类别:
-
资助金额:$176.85万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
PHASE I STUDY--CHIMERIC HUMAN /MURINE ANTI-GD2 MAB WITH BM-CSF IN NEUROBLASTOMA
-
批准号:6421185
-
项目类别:
-
资助金额:$15.58万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
Biology and Therapy of High Risk Neuroblastoma
-
批准号:7629709
-
项目类别:
-
资助金额:$195.07万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
Biology and Therapy of High Risk Neuroblastoma
-
批准号:8099438
-
项目类别:
-
资助金额:$201.55万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
Biology and Therapy of High Risk Neuroblastoma
-
批准号:7868531
-
项目类别:
-
资助金额:$213.6万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
PHASE 1 STUDY OF HUMAN GAMMA INTERFERON GENE-TRANSDUCED TUMOR CELLS
-
批准号:6421203
-
项目类别:
-
资助金额:$15.58万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
Biology and Therapy of High Risk Neuroblastoma
-
批准号:7430443
-
项目类别:
-
资助金额:$190.81万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
Biology and Therapy of High Risk Neuroblastoma
-
批准号:8506982
-
项目类别:
-
资助金额:$187.65万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
BIOLOGY AND THERAPY OF HIGH-RISK NEUROBLASTOMA
-
批准号:6767761
-
项目类别:
-
资助金额:$181.95万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
Biology and Therapy of High Risk Neuroblastoma
-
批准号:7271276
-
项目类别:
-
资助金额:$189.95万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
BIOLOGY AND THERAPY OF HIGH-RISK NEUROBLASTOMA
-
批准号:6633391
-
项目类别:
-
资助金额:$177.56万
-
财政年份:2000
-
负责人:ROBERT Charles SEEGER
-
依托单位:
海外基金